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Abstract
OBJECTIVES: Most studies on acute kidney injury (AKI) following open-heart surgery have focused on short-term outcome following
coronary artery bypass grafting. We reviewed the incidence, risk factors and outcome, including long-term survival, of AKI after aortic
valve replacement (AVR) in a population-based cohort.
METHODS: A retrospective review of 365 patients who underwent AVR for aortic stenosis during 2002–2011 was made. AKI was defined
according to the RIFLE criteria. All patients requiring dialysis were followed up in a centralized registry. Risk factors for AKI were analysed
with univariable and multivariable analysis, and survival was graphically presented with the Kaplan–Meier method.
RESULTS: The rate of AKI was 82/365 (22.5%); 40, 28 and 14 patients belonging to the Risk, Injury and Failure groups, respectively.
Preoperatively, 37 (45.1%) AKI patients had reduced kidney function. Transfusion of red blood cells, obesity and prolonged cardiopulmonary
bypass time were independent risk factors for AKI. Acute postoperative dialysis was required in 15 patients (4.1%), and 1 patient developed
dialysis-dependent end-stage renal disease. Major postoperative complications were more common in the AKI group (65 vs 22%, P < 0.001).
The 30-day mortality rate in the AKI group was 18%, as opposed to 2% in the non-AKI group (P < 0.001), with a 5-year survival rate of 66 vs
87%, respectively (P < 0.001). In multivariable analysis AKI was an independent predictor of operative mortality [odds ratio = 5.89, 95%
confidence interval (CI) = 1.99–18.91] but not of long-term survival (hazard ratio = 1.44, 95% CI = 0.86–2.42).
CONCLUSIONS: More than 1 in 5 patients (22.5%) who underwent AVR developed AKI postoperatively. AKI was associated with higher
morbidity and was an independent predictor of operative mortality. However, AKI was not a determinant of long-term survival.
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INTRODUCTION
Cardiac surgery-related acute kidney injury (AKI) (CS-AKI) is a
common and serious complication of open-heart surgery, asso-
ciated with increased morbidity as well as short- and long-term
mortality [1, 2]. Until 2004, when the Acute Dialysis Quality Initiative
published a consensus definition of AKI (the RIFLE criteria), com-
parison of studies on AKI was difficult because of widely differing
definitions [3]. These criteria were later accepted by the Acute
Kidney Injury Network with some modifications (the AKIN criteria)
[4]. Ultimately, the Kidney Disease: Improving Global Outcomes
(KDIGO) criteria that combines the RIFLE and the AKIN criteria was
published in 2012 [5] and today most studies use one of these
three classifications of AKI, thereby allowing better comparison of
epidemiological research.
According to the RIFLE criteria, classification of AKI may be
based on either a relative increase in serum creatinine (SCr) or an
episode of oliguria. AKI is graded according to severity into three
groups: Risk, Injury and Failure. The RIFLE criteria also define two
outcome measures (Loss and End-stage kidney disease) depend-
ing on the duration of renal replacement therapy (RRT).
In recent years, several risk factors for CS-AKI have been identi-
fied, mostly in studies conducted on patients undergoing coronary
artery bypass grafting (CABG). Risk factors can be divided into
patient-related (e.g. advanced age, female sex, diabetes mellitus,
pre-existing kidney disease and left ventricular impairment) or
operation-related [such as perioperative hypotension and pro-
longed cardiopulmonary bypass (CPB) time] [6].
Valvular heart surgery is a proven risk factor for AKI [7]. Aortic
valve replacement (AVR) is the second most common open-heart
procedure, after CABG, in most Western countries [8]. AKI follow-
ing AVR as well as the more recently developed technique of
transcatheter aortic valve replacement was a topic of a recent
review. However, none of the studies included in the review
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focused solely on AKI following AVR, but rather on AKI after
cardiac surgery in general [9]. In fact, there has been a lack of
studies focusing solely on the incidence, risk factors and outcomes
of AKI following conventional AVR. We therefore wanted to evalu-
ate the incidence and risk factors for AKI following AVR for aortic
stenosis (AS) in a population-based cohort. Furthermore, we also
investigated short-term outcome and long-term survival in AKI
patients.
MATERIALS ANDMETHODS
Patients
This was a retrospective whole-nation study of all patients who
underwent AVR for AS at Landspitali–National University Hospital
of Iceland between 1 January 2002 and 31 December 2011. The
hospital is the only institution performing open-heart surgery in
Iceland, and since 1986 over 7000 open-heart procedures have
been performed. Patients were identified through two separate
registries. Firstly, an electronic diagnosis and operation registry
was searched for patients who had undergone AVR with either
biological or mechanical prosthesis, with or without concomitant
CABG. Subsequently, a centralized cardiac surgery database at our
institution was used to identify patients, providing a 100% match
with the subset identified in the aforementioned registry.
Of the 436 patients who underwent AVR with or without surgical
coronary revascularization during the 10-year period, 71 patients
were excluded, 31 because of a history of previous cardiac surgery,
27 because AS was not the indication for surgery and 13 because of
missing data, since their patient charts were not found. None of
these patients died during surgery. This left 365 patients for further
analysis, of whom 298 (81.6%) received a biological prosthesis and
67 (18.4%) received a mechanical prosthesis.
Clinical parameters
Clinical information, obtained from patient charts and surgical
reports, was registered on a standardized data sheet using Excel
(Microsoft Corp., Redmond, WA, USA) and was reviewed by five of
the authors (Dadi Helgason, Sindri A. Viktorsson, Solveig Helgadottir,
Inga L. Ingvarsdottir and Tomas Gudbjartsson). Over 100 variables
were registered, e.g. gender, age, cardiovascular risk factors and pre-
vious medical history. History of myocardial infarction (MI), diabetes
mellitus, hypertension, dyslipidaemia and chronic heart failure was
defined as a prior diagnosis of these conditions at any time. The
modification of diet in renal disease (MDRD) study equation was
used to calculate preoperative estimated glomerular filtration rate
(eGFR) for each patient, and reduced preoperative renal function
was defined as eGFR <60 ml/min/1.73 m2. Information on left
ventricular ejection fraction and medication was also collected, in-
cluding antiarrhythmic drugs such as β-blockers, cholesterol-
lowering statins and anticoagulation or antiplatelet drugs. Patients’
symptoms were evaluated according to the New York Heart
Association (NYHA) classification, and their EuroSCORE (European
System for Cardiac Operative Risk Evaluation) was calculated [10].
In addition, information on preoperative haemoglobin, the sever-
ity of coronary artery disease (such as three-vessel disease, left
main stem stenosis), acute versus elective surgery, CPB time, aortic
cross-clamp time and skin-to-skin time was registered.
Hospital morbidity was assessed by means of intraoperative
and postoperative complications (minor/major) and length of
stay. Operative mortality was defined as the number of patients
who died ≤30 days from surgery.
Definition of acute kidney injury and
complications
AKI was defined according to the RIFLE criteria. The patient’s
highest postoperative SCr level in the first 7 days after surgery was
compared with baseline levels (defined as the preoperative SCr
level closest to surgery) and AKI patients classified into the Risk,
Injury or Failure group according to the relative degree of SCr
elevation (1.5-fold to 2-fold, >2-fold to 3-fold, and >3-fold, re-
spectively). AKI patients were compared with patients with normal
postoperative kidney function. The baseline SCr level was missing
in 15 patients and, in these cases, the mean baseline SCr value of
the study cohort was used instead.
Postoperative complications were categorized as either minor or
major. Minor complications included leg wound infection, urinary
tract infection, pleural effusion requiring drainage and pneumonia;
major complications included stroke, mediastinitis, endocarditis,
MI (defined as isolated ST-segment changes or a new left bundle
branch block on electrocardiogram along with elevation of creat-
ine kinase MB (CK-MB) of ≥70 μg/l), reoperation, sternum dehis-
cence and acute respiratory distress syndrome or multiple organ
failure (MOF). We also recorded bleeding (defined as the 24-h
postoperative chest tube output) and number of transfusions of
packed red blood cells (PRBCs) during the hospitalization period.
All patients were followed up regarding RRT and renal recovery
after surgery by using a centralized dialysis database in Iceland.
Follow-up
Patients were assigned a date and a cause of death or were identi-
fied as still living on 1 June 2013, using data from the Icelandic
National Population Registry. Overall survival (OS) was calculated
using the Kaplan–Meier method. The mean follow-up time was
4.7 years (range: 0–11.2 years) and none of the patients were lost
to follow-up.
Statistical methods
Continuous variables were compared between patients with and
without AKI with a t-test or Mann–Whitney U-test, depending on
whether or not the data were normally distributed. Categorical
variables were compared by using the χ2 test when the minimum
expected number was >1, otherwise the Fisher’s exact test was
used. Survival was plotted on a Kaplan–Meier curve and the
groups were compared with a log-rank test. A multivariable logis-
tic regression model of independent risk factors for AKI and pre-
dictors of operative mortality was pursued by using variables from
the univariable analysis with P-values less than 0.1 as predictor
variables, and reducing the model using a stepwise backwards
method and then adding factors with clinical reasoning until the
best model was found. The goodness of fit of these models was
tested with the Hosmer–Lemeshow test. Similarly, a Cox propor-
tional hazards model was used to find predictors of survival. All
factors known to have a possible effect on survival were used and
the model was again modified with a stepwise backwards method
and clinical reasoning. In the final model, all factors met the
requirements of proportional hazards assumption according to
the method of Grambsch and Therneau [11]. Odds ratios (ORs) in
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the logistic models and hazard ratios (HRs) in the Cox model are
reported, along with 95% confidence intervals (CIs).
The level of statistical significance was set at P < 0.050. All statis-
tical analyses were performed with R software version 3.1.2 (the R
Foundation, Austria) using the Survival, Epitools and Resource
Selection add-on packages.
The study was approved by the Icelandic National Bioethics
Committee and the Icelandic Data Protection Commission. As in-
dividual patients were not identified, obtaining individual consent
for the study was waived.
RESULTS
Rate
Eighty-two patients (22.5%) developed postoperative AKI accord-
ing to the RIFLE criteria. Of these patients, 40 (11.0%) had
Risk-stage AKI, 28 (7.7%) had Injury-stage AKI and 14 (3.8%) were
categorized as being at the Failure stage.
Demographic and perioperative data
Patient characteristics with and without AKI are presented in
Table 1, including cardiovascular risk factors, logistic EuroSCORE
and operative factors. The AKI group was 4 years older on average
and had a higher proportion of females. A higher proportion of
AKI patients had reduced preoperative renal function, lower
haemoglobin and more often diabetes mellitus; these patients
also had significantly higher body mass index (BMI), a significantly
higher logistic EuroSCORE and more severe heart failure symp-
toms according to the NYHA classification. A previous history of
MI and heart failure was more common in patients in the AKI
group. During surgery, the aortic cross-clamp time was on average
24 min longer in the AKI group, the CPB time was 40 min longer
and these patients more often required insertion of an intra-aortic
balloon pump (IABP) perioperatively. The lowest intraoperative
temperature was comparable in both groups. A stentless biological
valve was the most commonly implanted valve type in both
groups. Patients who received a stentless biological prosthesis
compared to stented bioprosthesis had on average 23 min longer
cross-clamp time, but the rate of AKI in the stentless versus
stented prosthesis groups was not statistically different (56.1 vs
48.8%, P = 0.30). Although the operation time for AVR with con-
comitant CABG was longer (CPB time 181 vs 136 min, P < 0.001),
there was no significant difference in the incidence of AKI
between isolated AVR and concomitant AVR + CABG.
Postoperative outcomes
Short-term complications are listed in Table 2. Overall, complica-
tions were more common in the AKI group, both minor (including
Table 1: Comparison of patient characteristics and intraoperative data for patients with AKI and normal renal function (non-AKI)
following AVR
Factor AKI (n = 82) Non-AKI (n = 283) P-value
Male 42 (51.2) 188 (66.4) 0.017
Age (years) 74.2 ± 7.69 70.3 ± 10.03 <0.001
BMI (kg/m2) 29.1 ± 5.92 27.2 ± 3.91 0.010
Diabetes mellitusa 20 (24.4) 34 (12.0) 0.010
Hypertensiona 65 (79.2) 189 (66.8) 0.043
Dyslipidaemiaa 38 (45.8) 117 (41.5) 0.51
History of smoking 44 (53.7) 189 (66.8) 0.041
History of MIa 19 (23.1) 29 (10.3) 0.005
Chronic heart failurea 29 (35.4) 49 (17.4) 0.001
Reduced preoperative renal functionb 37 (45.1) 72 (25.4) 0.001
Preoperative serum creatinine 97.9 ± 27.33 93.4 ± 44.09 0.25
Preoperative Hb (g/l) 131.9 ± 15.13 138.6 ± 13.17 <0.001
Preoperative anaemiac 29 (35.4) 65 (23.8) 0.034
NYHA III/IV 61 (74.4) 159 (56.2) 0.005
Logistic EuroSCORE (%) 14.1 ± 15.37 8.3 ± 10.17 0.001
LVEF (%) 55.3 ± 9.37 57.0 ± 8.63 0.15
Acute surgery 1 (1.2) 4 (1.4) 0.86
Urgent surgery 17 (20.7) 23 (8.1) 0.003
IABP 15 (18.3) 8 (2.8) <0.001
CABG 49 (59.8) 150 (53.0) 0.34
Cross-clamp time (min) 135.1 ± 40.21 110.7 ± 31.41 <0.001
CPB time (min) 191.4 ± 58.43 151.4 ± 45.62 <0.001
Stented biological valve 28 (34.1) 86 (30.4) 0.61
Stentless biological valve 46 (56.1) 138 (48.8) 0.30
Mechanical valve 8 (9.8) 59 (20.8) 0.034
Lowest intraoperative temperature (°C) 34.5 ± 1.01 34.6 ± 0.88 0.20
Data are number (%) or mean ± standard deviation.
aDefined as a prior diagnosis of these conditions at any time.
bDefined as eGFR <60 ml/min/1.73 m2.
cDefined as Hg <120 g/l in females and <135 g/l in men.
AVR: aortic valve replacement; AKI: acute kidney injury; BMI: body mass index; NYHA: New York Heart Association; IABP: intra-aortic balloon pump; CPB:
cardiopulmonary bypass; MI: myocardial infarction; LVEF: left ventricular ejection fraction; CABG: coronary artery bypass grafting.
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pneumonia, urinary tract infection and pleural effusion requiring
drainage) and major (including MI, sternal dehiscence, reopera-
tion for bleeding and MOF). Postoperative bleeding was on
average increased by 260 ml in the AKI group and they received 8
more units of PRBCs. The median length of intensive care unit
(ICU) stay was 5 days longer in patients with AKI, and they spent 4
days longer on the surgical ward.
Renal replacement therapy
Fifteen patients (4.1%) required acute RRT following the AVR pro-
cedure, but 1 patient who had been treated with chronic dialysis
before surgery was excluded from this analysis. Fourteen of these
patients received continuous renal replacement therapy (CRRT) in
the ICU. Four patients died while on CRRT and 6 patients required
intermittent dialysis after discharge from the ICU. Only 3 patients
(0.8%) required RRT for more than 4 weeks after surgery, including
1 patient who required RRT for more than 3 months and devel-
oped end-stage renal disease (0.27%).
Risk factors of acute kidney injury
Multivariable analysis of risk factors for AKI showed that transfu-
sions of PRBCs (OR = 1.64, 95% CI = 1.33–2.07, per 5 units), pro-
longed CPB time (OR = 1.10, 95% CI = 1.04–1.16, per 10 min) and
obesity (BMI > 30 kg/m2) (OR = 2.71, 95% CI = 1.41–5.22) were in-
dependent predictors of AKI (Table 3).
Survival
Operative mortality. Operative mortality was 9-fold higher in
patients with AKI than in patients without AKI: 18% when
compared with 2% (P < 0.001). The operative mortality was 10, 32
and 14% in the Risk, Injury and Failure groups, respectively, and
was significantly higher in every one of the three groups
compared with that in non-AKI patients (P < 0.050).
After adjustment for logistic EuroSCORE, CPB time and number
of PRBC transfusions, AKI proved to be an independent predictor
of operative mortality (OR = 5.89, 95% CI = 1.99–18.91) (Table 4).
Long-term survival. AKI patients had significantly lower 5-year
survival than non-AKI patients: 65.7% as opposed to 87.1%
(P < 0.001) (Fig. 1 ), where 5-year survival rate was 70.6, 60.5 and
63.5% in the Risk, Injury and Failure groups, respectively. However,
AKI was not a predictor of long-term survival in the Cox
proportional hazard analysis (HR = 1.44, 95% CI = 0.86–2.42)
(Table 5). The effect remained insignificant when patients who
Table 2: Short-term outcome after AVR, including short-term complications, length of hospital stay and operative mortality
Factor AKI (n = 82) Non-AKI (n = 283) P-value
Minor 69 (84.1) 171 (60.4) <0.001
Superficial wound infection 11 (13.4) 19 (6.7) 0.086
Atrial fibrillation 46 (78.0) 144 (65.2) 0.086
Pleural effusion 24 (29.3) 25 (8.8) <0.001
Pneumonia 24 (29.3) 16 (5.7) <0.001
Urinary tract infection 28 (34.1) 11 (3.9) <0.001
TIA 2 (2.4) 5 (1.8) 0.66
Major 53 (64.6) 63 (22.3) <0.001
Myocardial infarction 24 (29.3) 25 (8.8) <0.001
Sternal dehiscence 4 (4.9) 3 (1.1) 0.048
Stroke 2 (2.4) 6 (2.1) 1.00
Deep sternal infection 1 (1.2) 3 (1.1) 1.00
Reoperation for bleeding 23 (28.0) 31 (11.0) <0.001
Bleeding in the first 24 h (ml) 1320 ± 1063.6 1060 ± 770.6 0.041
Transfusions of PRBCs (units) 13.4 ± 11.09 5.5 ± 5.63 <0.001
ICU stay (days) 6 (1–80) 1 (0–15) <0.001
Surgical ward (days) 13 (0–127) 9 (0–41) <0.001
Operative mortality (≤30 days) 15 (18.3) 6 (2.1) <0.001
Number (%), mean ± standard deviation or median (range).
AVR: aortic valve replacement; AKI: acute kidney injury; TIA: transient ischaemic attack; PRBC: packed red blood cell; ICU: intensive care unit.
Table 3: Analysis of risk factors for AKI after AVR (Hosmer–
Lemeshow goodness-of-fit test; χ2 = 6.17, P = 0.63).
Factor OR (95% CI) P-value
PRBC transfusions (5 units, numerical
variable)
1.64 (1.33–2.07) <0.001
CPB time (10 min, numerical variable) 1.10 (1.04–1.16) 0.002
Obesity (BMI > 30): yes versus no 2.71 (1.41–5.22) 0.003
IABP: yes versus no 2.43 (0.81–7.53) 0.11
Anaemiaa 1.11 (0.58–2.16) 0.76
Hypertension: yes versus no 1.74 (0.90–3.53) 0.11
Sex: female versus male 1.56 (0.85–2.87) 0.15
Reduced preoperative renal function:
yes versus nob
1.30 (0.69–2.42) 0.42
Age (per year, cont. variable) 1.03 (0.995–1.078) 0.10
AVR: aortic valve replacement; AKI: acute kidney injury; OR: odds ratio;
CI: confidence interval; PRBC: packed red blood cell; CBP:
cardiopulmonary bypass; BMI: body mass index; IABP: intra-aortic
balloon pump.
aDefined as Hg <120 g/l in females and <135 g/l in men.
bDefined as eGFR <60 ml/min/1.73 m2
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died within 7 days from surgery were excluded from the analysis
(HR = 1.72, 95% CI = 0.99–2.99). Nonetheless, when patients who
lived longer than 7 days were categorized into two groups
according to their type of surgery; AKI was an independent
predictor of survival for patients who underwent AVR with
concomitant CABG (HR = 3.01, 95% CI = 1.43–6.27), but not for
isolated AVR patients (HR = 0.97, 95% CI = 0.36–2.67).
DISCUSSION
The results of this study show that the rate of AKI after AVR is high,
with more than one in five patients affected following the proced-
ure. This study also demonstrates that AKI is associated with
increased risk of other postoperative complications and a predict-
or of operative mortality. However, we found that AKI following
AVR is not an independent predictor of long-term survival.
AKI following open-heart surgery has been the subject of
several studies in recent years. Most of these studies have investi-
gated the incidence of AKI after CABG, with a rate ranging from 12
to 20% [1, 2]. To our knowledge only one prior study has focused
on AKI following AVR [12]. That study reported an AKI rate of 17%,
which is lower than in our cohort. The lower incidence might be
partly explained by the fact that only patients who underwent
isolated AVR were included. Our cohort, however, included both
AVR and patients who underwent concomitant AVR and CABG.
Although there was not a significant difference in the rate of AKI
between these groups, there was a trend towards a lower rate in
the isolated AVR group, or 19.9 vs 24.6% for patients who under-
went AVR + CABG (P = 0.34). Studies focusing on AKI following
open-heart procedures have reported AKI rates in their subanaly-
sis on valve procedures ranging between 25 and 49%—which is a
higher rate compared with the 22.5% found in the present study
[13, 14].
The reason for a higher incidence of AKI following AVR com-
pared with CABG is not fully understood. Patients who undergo
AVR are often older than CABG patients, their preoperative kidney
function is more often reduced and they generally undergo more
complex operations with longer CPB times [15].
This study identified several risk factors for AKI including
obesity, prolonged CPB time and transfusion with PRBCs, with
ORs in the range of 1.10–2.71. Reduced preoperative renal func-
tion and history of diabetes are among well-defined risk factors
for AKI in other studies [16] but did not reach statistical signifi-
cance in the present study. Importantly, patient cohorts differ
between studies; for instance diabetes is, for unknown reasons,
less common in Iceland than in many other western countries
[17]. Obesity is a risk factor for several postoperative complica-
tions, including AKI. The increased risk of postoperative AKI in
obese patients can partly be explained by an increased risk of
perioperative hypotension and insufficient volume resuscitation in
this patient group [18].
Prolonged CPB time is a well-known and major risk factor for
AKI [7, 14, 16]. The non-pulsatile flow of CPB causes vasoconstric-
tion and hypoperfusion of the kidneys, and the haemodilution
and inflammatory state caused by CPB are also thought to be con-
tributory factors [19]. To increase the power of statistical analysis,
we included patients who underwent isolated AVR as well as
patients who underwent AVR with concomitant CABG. Even
though the combined operations took on average 45 min longer,
the rates of AKI and operative mortality were not statistically dif-
ferent following these procedures.
Overall, the transfusion rates in our study were high compared
with transfusion rates following CABG in Iceland, where the rate has
been comparable with those reported in neighbouring countries
[20]. The reason for this higher rate could be that AVR, especially
with concomitant CABG, is a more complex procedure than iso-
lated CABG and carries an increased risk of bleeding. More restrict-
ive guidelines have since the time of this study been implemented
in Iceland with the aim of lowering perioperative transfusion rates.
Figure 1: Overall survival in the AKI and non-AKI groups (P < 0.001, log-rank
test). AKI: acute kidney injury.
Table 4: Predictors of operative mortality (Hosmer–
Lemeshow goodness-of-fit test; χ2 = 239.65, P < 0.001)
Factor OR (95% CI) P-value
AKI: yes versus no 5.89 (1.99–18.91) 0.002
Logistic EuroSCORE 1.04 (1.01–1.07) 0.002
PRBC transfusions (5 units, numerical
variable)
1.38 (1.08–1.76) 0.009
CPB time (10 min, numerical variable) 0.97 (0.87–1.07) 0.63
AKI: acute kidney injury; OR: odds ratio; CI: confidence interval; PRBC:
packed red blood cell; CBP: cardiopulmonary bypass.
Table 5: Predictors of long-term survival
Factor HR (95% CI) P-value
AKI: yes versus no 1.44 (0.86–2.42) 0.16
Logistic EuroSCORE 1.02 (1.002–1.031) 0.019
PRBC transfusions (5 units, numerical
variable)
1.17 (1.06–1.31) 0.003
Age (per year, cont. variable) 1.08 (1.04–1.12) <0.001
CPB time (10 min, numerical variable) 1.01 (0.96–1.06) 0.64
Sex: female versus male 0.99 (0.62–1.60) 0.96
Obesity (BMI >30): yes versus no 1.57 (0.95–2.59) 0.63
AKI: acute kidney injury; HR: hazard ratio; CI: confidence interval; PRBC:
packed red blood cell; CBP: cardiopulmonary bypass; BMI: body mass
index.
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According to our results, patients who received large numbers
of PRBC transfusions are at an increased risk of developing AKI, as
other studies have reported [14, 21]. In the present study the AKI
patients received 8 more units of PRBCs compared with non-AKI
patients; however, their 24-h postoperative chest tube output was
increased by only 260 ml. The reason for this discordant use of
PRBC transfusion in AKI patients is not fully known but can be par-
tially explained by the fact that AKI patients more often had pre-
operative anaemia compared with non-AKI patients.
The effect of transfusion on AKI is not fully explained by pre-
operative anaemia, perioperative and postoperative bleeding, as
transfusion remained a significant risk factor for AKI when re-
operation for bleeding and 24-h postoperative chest tube output
were included in the risk factor analysis. Some studies have sug-
gested that when blood is stored, red blood cells undergo
changes that cause impaired oxygen delivery, promote a proin-
flammatory state, and increase oxidative stress—resulting in injury
to organs, including the kidneys [21, 22].
We experienced a relatively high rate (15%) of reoperation in
patients. Possible explanations include a lower institutional thresh-
old for bringing patients back for re-exploration. In addition, our
study included both acute surgeries and AVR with concomitant
CABG. In our patient cohort, combined surgery was associated
with increased risk of postoperative bleeding compared with iso-
lated AVR but other studies have shown a high reoperation rate
following acute operations [23]. Despite the high reoperation rate,
the rate of other complications and operative mortality were in
line with other studies and we believe this high reoperation rate
does not affect the generalizability of the main results of this
study.
Of all patients in this study, 4.1% required RRT after surgery. Of
these, 3 patients (0.8%) became dependent on haemodialysis for
more than 4 weeks, with only 1 patient requiring dialysis for more
than 3 months. Other studies on AKI after cardiac surgery have
found rates of haemodialysis ranging between 1 and 5% [9], but
when CRRT in the ICU is included, the rate is higher, or up to 8%
[13, 24]. The overall RRT rate in our study is therefore comparable
with that reported in other studies. The outcome of long-term
dialysis must be regarded as excellent, since the only patient
requiring dialysis for more than 3 months only needed dialysis
treatment for 108 days and remained free of dialysis during
the follow-up. Thus, none of the patients became permanently
dependent on dialysis after surgery.
In the present study, AKI was associated with an increased risk of
other complications and the operative mortality of the AKI group
was nine times that of the non-AKI group. Overall long-term sur-
vival was also significantly lower in AKI patients. After correcting for
preoperative and perioperative factors, AKI was found to be an in-
dependent predictor of operative mortality. We used a stepwise
method with clinical reasoning to find the best model for predictors
of operative mortality. Since only 21 patients died within 30 days,
the stepwise method can lead to a selection bias of covariables. In
addition, the predictability of the model was low according to the
Hosmer–Lemeshow goodness-of-fit test. Therefore, although these
results are suggestive, they should be interpreted with caution. Even
so, AKI did not prove to be an independent predictor of long-term
survival. According to the RIFLE criteria, patients can develop post-
operative AKI during the first 7 postoperative days. However, some
non-AKI patients could have died of other reasons before they
developed AKI, which would skew the HR for AKI. Therefore, we
performed a landmark analysis where all the patients who died
within 7 days from surgery (the time frame for diagnosing AKI)
were excluded. In that analysis, AKI did not prove to be an inde-
pendent predictor of survival.
Our findings are different from those of most previous studies
on this topic that show that AKI can have a profound effect on
both short- and long-term patient survival. However, so far most
studies have focused on AKI either following isolated CABG or
cardiac surgery in general. To study the effect of AKI following
AVR further, we performed a subanalysis where we categorized
the patients into two groups according to their type of surgery
(AVR or AVR + CABG). In the AVR + CABG group AKI was a signifi-
cant predictor of long-term survival, but not in the isolated AVR
group. A probable explanation for the difference of our results
compared with other studies is the different patient cohort.
Generally, patients undergoing AVR + CABG have different risk
factors for atherosclerosis affecting the risk of AKI, kidney recovery,
progression to chronic kidney disease and OS.
To our knowledge, our study is one of the first studies that
focuses on the incidence and outcome of AKI following AVR
surgery. Our findings not only are useful as a platform for other
studies but also highlight the importance of AKI following cardiac
surgery, especially valvular procedures. Furthermore, we think the
identified risk factors of AKI should be taken into consideration in
the pre-, peri- and postoperative periods of this group of patients.
We used the RIFLE criteria in their original form to evaluate AKI.
Soon after the criteria were published in 2004, they were adopted
and modified by the Acute Kidney Injury Network and repub-
lished (as the AKIN criteria) in an effort to enhance both sensitivity
and specificity [4]. However, studies comparing the criteria have
not shown any reliable superiority of the AKIN criteria [25]. In
some of the most recent publications, new biomarkers for AKI
have been used, such as neutrophil gelatinase-associated lipocalin
(n-gal) and cystatin C. These studies show promising results for the
markers in early detection of AKI. However, in our retrospective
study we were not able to use these markers as they were not
measured routinely.
The strengths of the study were that the patients were found
using two separate registries and that the phenotype of AKI was
well defined, with access to a centralized nationwide dialysis regis-
try. All the patients were operated on and treated at a single centre,
and they were therefore less likely to be affected by a selection bias.
Furthermore, none of the patients were lost to follow-up. One of
the limitations of this study was its retrospective observational
nature, making it unable to demonstrate causal effects.
In summary, this study has shown that the incidence of AKI after
AVR in Iceland is higher than that after CABG, but similar to that in
other studies on valvular procedures. It identified risk factors for
AKI that have been reported in other studies, including PRBC trans-
fusions, obesity and prolonged CPB time. Development of AKI is
associated with higher morbidity and is an independent predictor
of operative mortality. In this study, however, AKI was not a deter-
minant of long-term survival.
Further studies are needed on the long-term outcome—both
survival and renal recovery—of AKI patients following AVR.
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Aortic stenosis and renal failure are mainly diseases of elderly population. Both of
them consume a disproportionate share of healthcare resources worldwide. Each
causes severe morbidity and mortality by itself, yet their coexistence alters upside
down the clinical course. Helgason et al. published survival data of patients who
develop acute kidney injury (AKI) after aortic valve replacement (AVR) for aortic sten-
osis. AKI is a frequent (22.5%) complication of AVR.
Authors defined transfusion of red blood cells, obesity and prolonged cardiopul-
monary bypass time as independent risk factors for AKI [1]. According to recent
studies obesity is a risk factor for renal failure even in healthy population. We want to
underscore the possible contribution of obesity on renal failure in aortic stenosis
patients. Even metabolically healthy overweight or obese individuals seem to be at
higher risk for renal insufficiency. In a prospective cohort study, over 60 000 healthy
individuals were stratified into underweight, normal weight, overweight and obese
groups [2]. At baseline, all participants were free from renal insufficiency. Compared
to those with normal weight, five-year cumulative incidence of renal insufficiency
was higher among overweight or obese participants, with adjusted differences of 3.5
(95% CI 0.9-6.1) and 6.7 (95% CI 3.0-10.4) cases per 1000 respectively. The effect of
obesity on eGFR increases with age, especially after age forty. According to another
study even weight gain increases the risk for renal insufficiency if one remains within
the "normal" category of body mass index [3]. In the light of present studies there is
no doubt that obese aortic stenosis patients deserve special attention to prevent
kidney injury especially after AVR. Chronic kidney disease may be under-recognized,
which may contribute to the rising prevalence of end-stage renal disease. Screening
of obese aortic stenosis patients even at early stages of the disease is crucial as renal
insufficiency also increases the progression of stenosis. More than 1 in 5 AKI after
AVR is a striking complication ratio. Physicians must be aware of kidney injury in
obese AS patients. Risk modification with weight loss in early stages of aortic stenosis
may prevent AKI after AVR and lengthen survival.
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